Stock comparison
United Therapeutics
UTHR$24.13BHealthcare Market cap, Sector
Vera Therapeutics
VERA$2.44BHealthcare Market cap, Sector
Overall winner
United Therapeutics
UTHR 70 VERA
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
UTHR7wins
0winsVERA
71B
F15
76B
D54
76B
F36
62C
F13
46D
F0
64C
F24
64C
F28
Side-by-side metrics
| Metric | UTHR | VERA |
|---|---|---|
| Market cap | Winner: $24.13B | $2.44B |
| P/E (TTM) | 19.2x | - Winner |
| EV/EBIT | 15.2x | - Winner |
| ROIC (TTM) | Winner: 18.81% | -66.5% |
| Gross margin | Winner: 86.58% | 0.0% |
| Net margin | Winner: 40.61% | 0.0% |
| Revenue CAGR 5y | 17.22% | - |
| EPS CAGR 5y | 29.84% | - |
| Debt / Equity | Winner: - | 0.2x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- ROIC (TTM)18.81%vs -66.5%+128%
- Gross margin86.58%vs 0.0%+100%
- Net margin40.61%vs 0.0%+100%
- Debt / Equity-vs 0.2x+100%
VERA leads on
- EV/EBIT-vs 15.2x+156%
- P/E (TTM)-vs 19.2x+138%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.